MeiraGTx Holdings (MGTX) Receivables (2022 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Receivables came in at $9.1 million in Q4 2025, up 88.28% YoY from $4.8 million in Q4 2024, and up 21.12% on a QoQ basis from $7.5 million in Q3 2025.
MeiraGTx Holdings (MGTX) Receivables (2022 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 4 years of Receivables data on file, last reported at $9.1 million in Q4 2025.
- Quarterly Receivables rose 88.28% year-over-year to $9.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.1 million (up 88.28% YoY) and the FY2025 annual result came in at $8.9 million, up 366.31% from the prior year.
- Receivables climbed to $9.1 million in Q4 2025, from $7.5 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $32.7 million in Q2 2023 to a low of -$4.1 million in Q1 2025.
- A 4-year average of $10.7 million and a median of $8.3 million in 2025 frame the typical range for Receivables.
- The widest YoY moves for Receivables: up 88.28% in 2025, down 137.72% in 2025.
- Tracing MGTX's Receivables over 4 years: stood at $23.7 million in 2022, then tumbled by 45.17% to $13.0 million in 2023, then plunged by 62.92% to $4.8 million in 2024, then soared by 88.28% to $9.1 million in 2025.
- The last three Receivables figures came in at $9.1 million (Q4 2025), $7.5 million (Q3 2025), and $2.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.93 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.06 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1.84 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 912.74 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 215.33 Mn |
| 10 | MeiraGTx Holdings | 1.10 Bn | 1.03 Bn | - | 9.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.08 Mn |
| Sep 30, 2025 | 7.50 Mn |
| Jun 30, 2025 | 2.32 Mn |
| Mar 31, 2025 | -4.12 Mn |
| Dec 31, 2024 | 4.82 Mn |
| Sep 30, 2024 | 4.70 Mn |
| Jun 30, 2024 | 1.63 Mn |
| Mar 31, 2024 | 10.92 Mn |
| Dec 31, 2023 | 13.00 Mn |
| Sep 30, 2023 | 22.40 Mn |
| Jun 30, 2023 | 32.69 Mn |
| Dec 31, 2022 | 23.71 Mn |